Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| ACER Options Chain |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on September 19, 2023, ACER opened at $0.84, traded as high as $0.86 and as low as $0.83, and closed at $0.85. Trading volume was a total of 268.10K shares. On September 20, 2023, ACER opened at $0.85, traded as high as $0.86 and as low as $0.83, and closed at $0.83. Trading volume was a total of 162.90K shares. On September 21, 2023, ACER opened at $0.82, traded as high as $0.84 and as low as $0.82, and closed at $0.83. Trading volume was a total of 134.80K shares. On September 22, 2023, ACER opened at $0.81, traded as high as $0.84 and as low as $0.80, and closed at $0.80. Trading volume was a total of 126.10K shares. On September 25, 2023, ACER opened at $0.81, traded as high as $0.83 and as low as $0.80, and closed at $0.80. Trading volume was a total of 89.80K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/27/2013 | |
| End date: | 09/25/2023 | |
| Start price/share: | $23.44 | |
| End price/share: | $0.80 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -96.59% | |
| Average Annual Total Return: | -28.66% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $341.45 | |
| Years: | 10.00 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 09/19/2023 | $0.84 | $0.86 | $0.83 | $0.85 | 268.10K |
| 09/20/2023 | $0.85 | $0.86 | $0.83 | $0.83 | 162.90K |
| 09/21/2023 | $0.82 | $0.84 | $0.82 | $0.83 | 134.80K |
| 09/22/2023 | $0.81 | $0.84 | $0.80 | $0.80 | 126.10K |
| 09/25/2023 | $0.81 | $0.83 | $0.80 | $0.80 | 89.80K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19. |
| ACER Historical Closing Prices | |
| Date | Close |
| 09/19/2023 | $0.85 |
| 09/20/2023 | $0.83 |
| 09/21/2023 | $0.83 |
| 09/22/2023 | $0.80 |
| 09/25/2023 | $0.80 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history
|
Free ACER Email Alerts:
